216 related articles for article (PubMed ID: 32324157)
1. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies.
Clark GRC; Strachan JA; McPherson A; Digby J; Mowat C; Steele RJC; Fraser CG
Clin Chem Lab Med; 2020 Nov; 58(12):2073-2080. PubMed ID: 32324157
[TBL] [Abstract][Full Text] [Related]
2. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
Clark GR; Godfrey T; Purdie C; Strachan J; Carey FA; Fraser CG; Steele RJ
J Med Screen; 2024 Mar; 31(1):21-27. PubMed ID: 37469171
[TBL] [Abstract][Full Text] [Related]
3. Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening.
Fraser CG; Rubeca T; Rapi S; Chen LS; Chen HH
Clin Chem Lab Med; 2014 Aug; 52(8):1211-6. PubMed ID: 24637000
[TBL] [Abstract][Full Text] [Related]
4. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
5. Deprivation and faecal haemoglobin: implications for bowel cancer screening.
Digby J; McDonald PJ; Strachan JA; Libby G; Steele RJ; Fraser CG
J Med Screen; 2014 Jun; 21(2):95-7. PubMed ID: 24803480
[TBL] [Abstract][Full Text] [Related]
6. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
7. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
8. Do faecal test-based colorectal cancer screening pilots provide data that are reflected in subsequent programmes? Evidence from interval cancer proportions.
Clark GR; Steele RJ; Fraser CG
Ann Clin Biochem; 2022 Nov; 59(6):450-452. PubMed ID: 36031942
[TBL] [Abstract][Full Text] [Related]
9. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
10. Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJ
J Med Screen; 2023 Dec; 30(4):184-190. PubMed ID: 37229658
[TBL] [Abstract][Full Text] [Related]
11. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
[TBL] [Abstract][Full Text] [Related]
12. Faecal haemoglobin: Measurement, applications, and future potential.
Fraser CG
Best Pract Res Clin Gastroenterol; 2023 Oct; 66():101833. PubMed ID: 37852705
[TBL] [Abstract][Full Text] [Related]
13. Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.
Clark GR; Digby J; Fraser CG; Strachan JA; Steele RJ
J Med Screen; 2022 Mar; 29(1):26-31. PubMed ID: 34806935
[TBL] [Abstract][Full Text] [Related]
14. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
16. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
[TBL] [Abstract][Full Text] [Related]
17. Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening.
Kaalby L; Deding U; Al-Najami I; Berg-Beckhoff G; Bjørsum-Meyer T; Laurberg T; Shaukat A; Steele RJC; Koulaouzidis A; Rasmussen M; Kobaek-Larsen M; Baatrup G
BMC Med; 2023 Jan; 21(1):29. PubMed ID: 36691009
[TBL] [Abstract][Full Text] [Related]
18. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
Clark GR; Fraser CG; Strachan JA; Steele RJ
J Med Screen; 2022 Dec; 29(4):249-254. PubMed ID: 35747907
[TBL] [Abstract][Full Text] [Related]
19. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
20. Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies.
Li SJ; Sharples LD; Benton SC; Blyuss O; Mathews C; Sasieni P; Duffy SW
J Med Screen; 2021 Sep; 28(3):277-285. PubMed ID: 33342370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
